Standard BioTools Reports Third Quarter and Year-to-Date 2023 Financial Results
07.11.2023 - Year-to-date revenue growth, gross margin expansion and operating expense reduction are testament to continued execution against financial objectivesPlanned merger with SomaLogic activates strategic M&A thesis SOUTH SAN FRANCISCO, Calif., Nov. ...